Sport Integrity Australia CEO warns athletes using ADHD medications
Athletes are being reminded to only use medication that is prescribed for a formal ADHD diagnosis, and to ensure they understand the TUE requirements
Sport Integrity Australia CEO Dr Sarah Benson has expressed concerns about the number of Australian athletes using medication for Attention Deficit Hyperactivity Disorder (ADHD) without a formal diagnosis or without the medication having been prescribed to them.
The use of ADHD medication without a formal diagnosis or an appropriate prescription can have serious anti-doping consequences for athletes, particularly where the substances are prohibited in competition and require a Therapeutic Use Exemption (TUE) for legitimate use in sport.
Many athletes with ADHD rely on stimulant medications such as methylphenidate (for example, Ritalin and Concerta) or dexamphetamine-based treatments (for example, Adderall and Vyvanse).
These substances are listed on the World Anti-Doping Agency’s Prohibited List (S6 Stimulants) due to their potential performance-enhancing effects.
Generally, athletes can use ADHD medication in sport if they have a medical diagnosis and it is part of a legitimate medical treatment.
In recent cases, athletes sought retroactive TUEs following their positive test. However, if an athlete does not have a formal diagnosis prior to using the medication, and/or the medication was not prescribed to them, a retroactive TUE cannot be approved and the athlete can face sanctions
In Australia, TUEs are managed and approved by the Australian Sports Drug Medical Advisory Committee (ASDMAC).
The original press release can be found here:https://www.sportintegrity.gov.au/news/media-statements/2026-07/ceo-warns-athletes-adhd-medications
